OTLK logo

Outlook Therapeutics (OTLK) Total Expenses

Annual Total Expenses

$71.70 M
+$18.58 M+34.97%

September 30, 2024


Summary


Performance

OTLK Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKexpensesmetrics:

Quarterly Total Expenses

$22.88 M
+$3.31 M+16.94%

September 1, 2024


Summary


Performance

OTLK Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKexpensesmetrics:

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

OTLK Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+35.0%+121.6%
3 y3 years+38.6%+70.3%
5 y5 years+116.1%+260.8%

OTLK Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+38.6%at high+234.6%
5 y5-yearat high+116.1%at high+260.8%
alltimeall timeat high+234.4%at high+479.4%

Outlook Therapeutics Total Expenses History

DateAnnualQuarterly
Sep 2024
$71.70 M(+35.0%)
-
Sep 2024
-
$22.88 M(+16.9%)
Jun 2024
-
$19.56 M(+3.3%)
Mar 2024
-
$18.94 M(+83.5%)
Dec 2023
-
$10.32 M(-17.1%)
Sep 2023
$53.13 M(-15.8%)
$12.46 M(-31.3%)
Jun 2023
-
$18.14 M(+165.3%)
Mar 2023
-
$6.84 M(-56.4%)
Dec 2022
-
$15.69 M(+12.2%)
Sep 2022
$63.07 M(+21.9%)
$13.99 M(-17.8%)
Jun 2022
-
$17.02 M(-10.0%)
Mar 2022
-
$18.91 M(+43.8%)
Dec 2021
-
$13.15 M(-2.1%)
Sep 2021
$51.73 M(+42.4%)
$13.44 M(+17.1%)
Jun 2021
-
$11.47 M(-9.1%)
Mar 2021
-
$12.63 M(-11.0%)
Dec 2020
-
$14.19 M(+41.7%)
Sep 2020
$36.31 M(+9.5%)
$10.01 M(-15.0%)
Jun 2020
-
$11.77 M(+85.7%)
Mar 2020
-
$6.34 M(-22.5%)
Dec 2019
-
$8.18 M(-20.1%)
DateAnnualQuarterly
Sep 2019
$33.18 M(+1.4%)
$10.24 M(+65.7%)
Jun 2019
-
$6.18 M(-20.7%)
Mar 2019
-
$7.79 M(-13.3%)
Dec 2018
-
$8.98 M(-31.9%)
Sep 2018
$32.73 M(-17.5%)
$13.19 M(+65.0%)
Jun 2018
-
$7.99 M(+5.1%)
Mar 2018
-
$7.60 M(+92.4%)
Dec 2017
-
$3.95 M(-32.0%)
Sep 2017
$39.69 M(-26.9%)
$5.81 M(-23.9%)
Jun 2017
-
$7.64 M(-6.2%)
Mar 2017
-
$8.14 M(-55.0%)
Dec 2016
-
$18.10 M(+73.2%)
Sep 2016
$54.33 M(+4.9%)
$10.45 M(-53.6%)
Jun 2016
-
$22.52 M(+470.4%)
Mar 2016
-
$3.95 M(-77.3%)
Dec 2015
-
$17.41 M(-2.6%)
Sep 2015
$51.78 M(+141.5%)
$17.87 M(+44.8%)
Jun 2015
-
$12.34 M(-14.9%)
Mar 2015
-
$14.50 M(+104.8%)
Dec 2014
-
$7.08 M
Sep 2014
$21.44 M
-

FAQ

  • What is Outlook Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Outlook Therapeutics?
  • What is Outlook Therapeutics annual total expenses year-on-year change?
  • What is Outlook Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly total expenses year-on-year change?

What is Outlook Therapeutics annual total expenses?

The current annual total expenses of OTLK is $71.70 M

What is the all time high annual total expenses for Outlook Therapeutics?

Outlook Therapeutics all-time high annual total expenses is $71.70 M

What is Outlook Therapeutics annual total expenses year-on-year change?

Over the past year, OTLK annual total expenses has changed by +$18.58 M (+34.97%)

What is Outlook Therapeutics quarterly total expenses?

The current quarterly total expenses of OTLK is $22.88 M

What is the all time high quarterly total expenses for Outlook Therapeutics?

Outlook Therapeutics all-time high quarterly total expenses is $22.88 M

What is Outlook Therapeutics quarterly total expenses year-on-year change?

Over the past year, OTLK quarterly total expenses has changed by +$12.55 M (+121.61%)